Brief: SIX Exchange Regulation Opens Investigation Against Relief Therapeutics For Possible Violation Of Ad-Hoc Publicity Rules
June 10 (Reuters) - SIX EXCHANGE REGULATION:
* OPENS INVESTIGATION AGAINST RELIEF THERAPEUTICS HOLDING AG
ON
JUNE 10, 2021 FOR POSSIBLE VIOLATION OF AD HOC PUBLICITY RULES
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on MindMaze Therapeutics Holding SA
See all newsBrief: Mindmaze Therapeutics Announces CHF 8.0 Million Strategic Equity Financing
Brief: Relief Therapeutics Shareholders Approve Business Combination With Neurox
Brief: Relief Therapeutics Receives FDA Response To Qidp Request For Rlf-Td011
Brief: Relief Therapeutics Says Interim CEO Michelle Lock Has Completed Her Transitional Mandate
Swiss stocks - Factors to watch on May 13